Systemic Capillary Leak Syndrome Resulting from Gemcitabine Treatment in Renal Cell Carcinoma: A Case Report
Authors: Pulkkanen, K.; Kataja, V.; Johansson, R.
Source: Journal of Chemotherapy, Volume 15, Number 3, 2003 , pp. 287-289(3)
Publisher: Maney Publishing
Abstract:In a few cases, gemcitabine (GCB) has been shown to result in systemic capillary leak syndrome (SCLS) in the treatment of non-small cell lung, pancreatic, and ovarian carcinomas. SCLS is a life-threatening condition characterized by increased capillary permeability resulting in manifest pulmonary and peripheral edema. Usually SCLS responds successfully to corticosteroid therapy and diuretics. We present a case where GCB treatment likely resulted in SCLS in a male patient with metastatic renal cell carcinoma (RCC) in the absence of predisposing cardiac, pleural, or pulmonary disease.
Document Type: Research Article
Publication date: 2003-01-01